I85PREP
⌘ K
CPAN study materials
CPAN study resources

Shallow Breathing and a High CO2 in a Patient with OSA on a PCA

CPAN · Put your knowledge to work in context.

All case studies

Shallow Breathing and a High CO2 in a Patient with OSA on a PCA

Mr. R, 58, has severe obstructive sleep apnea (uses CPAP at home, AHI 42) and takes oxycodone 10 mg twice daily for chronic back pain. He is 25 minutes into Phase I recovery after an open inguinal hernia repair under general anesthesia with sevoflurane, rocuronium reversed with sugammadex, fentanyl 150 mcg, and no regional block. Blood pressure is 148/86, HR 96, respirations 8 and shallow, SpO2 91% on 4 L/min nasal cannula, and nasal capnography reads 58 mmHg. He arouses only to firm voice or a sternal rub and responds with a groan (RASS −3); when momentarily awake he rates pain 8/10. The surgeon ordered a hydromorphone PCA, 0.2 mg demand, 10-minute lockout, no basal, and it is running. The PCA history shows four delivered demands in the past 12 minutes.

1. Interpret the respiratory findings. Which elements support opioid-induced ventilatory impairment versus residual neuromuscular blockade, upper airway obstruction, or atelectasis, and why does a pain score of 8/10 not reassure you?

Read the worked answer

Leading problem: opioid-induced ventilatory impairment layered on OSA-related upper airway obstruction.

  • Capnography is the decisive data point. EtCO2 58 mmHg with a rate of 8 is alveolar hypoventilation. Desaturation to 91% is a late sign, and a reassuring SpO2 on supplemental oxygen can mask a rising CO2.
  • Depth of sedation: RASS −3 with arousal only to firm voice is more than expected 25 minutes after a short hernia repair. Sedation and respiratory rate must be read together; sedation usually precedes measurable hypoventilation.
  • Opioid load: fentanyl 150 mcg intraoperatively plus hydromorphone 0.8 mg delivered in 12 minutes via PCA. Chronic oxycodone produces only partial cross-tolerance to hydromorphone. A PCA with no basal setting lowers but does not eliminate risk, particularly with OSA.
  • Upper airway obstruction probably coexists: shallow, snoring respirations that improve with jaw thrust or head-up positioning, and a capnogram that does not square up.
  • Residual neuromuscular blockade: less likely with sugammadex and a documented reversal, but must be excluded objectively - sustained head lift ≥5 seconds, TOF ratio ≥0.9, no diplopia. Residual block compounding opioids in OSA is a dangerous combination.
  • Atelectasis produces hypoxemia with increased work of breathing, not bradypnea with sedation and hypercapnia.
  • Why 8/10 does not reassure: pain reporting is arousal-dependent and tolerance shifts the dose-response curve. Respiratory rate, sedation score, and EtCO2 are the safety gauges, not the pain score.

2. Prioritize your actions for the next five minutes, and state what you stop or deliberately avoid.

Read the worked answer
  1. Stop the opioid delivery. Pause the PCA - every additional demand adds to the ventilatory depression. Do not discard it yet; you may need the history.
  2. Call for help - anesthesia provider and a second nurse - and describe the problem in clinical terms ("respiratory depression, EtCO2 58, RASS −3"), not "he's sleepy."
  3. Airway and ventilation before oxygen. Jaw thrust, head of bed up 30-45 degrees, oral airway if no gag reflex, and CPAP if he tolerates it (splints the pharyngeal airway in OSA). Titrate oxygen to SpO2 92-96%; do not chase 100% while minute ventilation is inadequate.
  4. Monitor continuously - capnography, pulse oximetry, ECG - and document vital signs and RASS every 5 minutes, reassessing after each intervention.
  5. Verify reversal with head lift, grip strength, and TOF if available.
  6. Naloxone is a rescue, not a reflex. If airway maneuvers and stimulation do not restore rate and EtCO2 within a few minutes, give naloxone 0.04 mg IV titrated every 1-2 minutes. Small titrated doses restore ventilation while avoiding an abrupt pain and catecholamine surge. Anticipate re-narcotization because naloxone is shorter-acting than hydromorphone, and be ready for repeat dosing or an infusion.
  7. Screen for confounders: glucose, temperature, residual volatile agent, any other sedating drug given in the OR.
  8. Escalate if hypercapnia worsens, SpO2 falls despite maneuvers, or he cannot be aroused after naloxone: prepare for bag-mask ventilation, possible reintubation, and an arterial blood gas.

3. Twenty minutes later: RASS 0, RR 14, SpO2 95% on 3 L/min, EtCO2 46 mmHg, pain 9/10. Describe your analgesia plan, monitoring, and handoff.

Read the worked answer

Analgesia - build multimodal coverage before adjusting the opioid.

  • Scheduled acetaminophen and, if renal function and surgical hemostasis permit, an NSAID; request a surgeon-performed local infiltration or TAP block for somatic pain.
  • Consider low-dose ketamine or a lidocaine infusion only under an institutional protocol with an anesthesia order.
  • If the PCA is restarted: lower demand dose (e.g., 0.1-0.15 mg), lockout of at least 10 minutes, no basal, patient-controlled only. A basal infusion in a patient with OSA is the highest-risk configuration.
  • Teach the patient and family that only the patient presses the button; a proxy pressing for him is a common cause of oversedation.

Monitoring. Continuous oximetry and capnography for 12-24 hours, hourly RASS and respiratory rate documented, CPAP available and encouraged during sleep. Observe a full respiratory cycle and the waveform, not just the number.

Handoff (SBAR). Report the event (nadir RR 8, EtCO2 58, RASS −3, SpO2 91%), interventions and response, cumulative opioid exposure, any naloxone given, the revised pain plan, OSA/CPAP status, and explicit monitoring weaning criteria. File an adverse drug event report and obtain a documented plan from the anesthesia provider rather than resuming the original order.